Pharmaceutical

60 Degrees pauses Phase IIB Covid-19 trial for tafenoquine

The company plans to refile the IND after assessing the feasibility of US FDA-suggested trial modifications.

Sep 19, 2023 - 20:00
60 Degrees pauses Phase IIB Covid-19 trial for tafenoquine
The company plans to refile the IND after assessing the feasibility of US FDA-suggested trial modifications.
Read the original article

Tags:

Previous Article

Otsuka and Astex’s oral Inaqovi wins European approval for AML

Next Article

Pelican and Primordial Genetics merge to form biotech company Primrose Bio

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Grifols gears up for FDA approval of fibrinogen replacement therapy

Grifols gears up for FDA approval of fibrinogen replace...

Feb 14, 2024

Did the government get a bad deal on the Covid-19 boosters?

Did the government get a bad deal on the Covid-19 boost...

Sep 28, 2023

Opinion: The next Census could undercount the number of disabled Americans by 20 million

Opinion: The next Census could undercount the number of...

Nov 27, 2023